FI951155L - Farmaseuttinen valmiste - Google Patents
Farmaseuttinen valmiste Download PDFInfo
- Publication number
- FI951155L FI951155L FI951155A FI951155A FI951155L FI 951155 L FI951155 L FI 951155L FI 951155 A FI951155 A FI 951155A FI 951155 A FI951155 A FI 951155A FI 951155 L FI951155 L FI 951155L
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutical preparation
- pharmaceutical
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9404928A GB2287880A (en) | 1994-03-14 | 1994-03-14 | Production of sustained release compositions |
| GB9411842A GB9411842D0 (en) | 1994-06-14 | 1994-06-14 | Pharmaceutical preparation |
| EP94308493A EP0654263B1 (en) | 1993-11-23 | 1994-11-17 | Method for preparing a sustained release composition |
| GB9423498A GB9423498D0 (en) | 1994-11-21 | 1994-11-21 | Pharmaceutical preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI951155A0 FI951155A0 (fi) | 1995-03-13 |
| FI951155L true FI951155L (fi) | 1995-09-15 |
| FI951155A7 FI951155A7 (fi) | 1995-09-15 |
Family
ID=27442925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI951155A FI951155A7 (fi) | 1994-03-14 | 1995-03-13 | Farmaseuttinen valmiste |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0672416A1 (fi) |
| JP (1) | JPH0840905A (fi) |
| AU (1) | AU694475B2 (fi) |
| CA (1) | CA2144500A1 (fi) |
| FI (1) | FI951155A7 (fi) |
| NO (1) | NO950950L (fi) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9519363D0 (en) | 1995-09-22 | 1995-11-22 | Euro Celtique Sa | Pharmaceutical formulation |
| GB9614902D0 (en) * | 1996-07-16 | 1996-09-04 | Rhodes John | Sustained release composition |
| DE19729487A1 (de) * | 1997-07-10 | 1999-01-14 | Dresden Arzneimittel | Verfahren zur Herstellung von Wirkstoff-Zubereitungen mit kontrollierter Freisetzung aus einer Matrix |
| KR20010034770A (ko) * | 1998-04-17 | 2001-04-25 | 우에하라 아끼라 | 멀티플 유닛 타입 서방성 정제 |
| DE19923551A1 (de) * | 1999-05-21 | 2000-11-30 | Lohmann Therapie Syst Lts | Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht |
| WO2004026262A2 (en) * | 2002-09-23 | 2004-04-01 | Verion, Inc. | Abuse-resistant pharmaceutical compositions |
| GB2403711A (en) * | 2003-07-07 | 2005-01-12 | Gw Pharma Ltd | Drug dispenser with controlled access |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4132753A (en) * | 1965-02-12 | 1979-01-02 | American Cyanamid Company | Process for preparing oral sustained release granules |
| GB8613688D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| SE9003296L (sv) * | 1990-10-16 | 1992-04-17 | Kabi Pharmacia Ab | Foerfarande foer att formulera laekemedel |
| US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| SE9200858L (sv) * | 1992-03-20 | 1993-09-21 | Kabi Pharmacia Ab | Metod för framställning av pellets med fördröjd frisättning |
-
1995
- 1995-03-02 EP EP95301337A patent/EP0672416A1/en not_active Withdrawn
- 1995-03-13 CA CA002144500A patent/CA2144500A1/en not_active Abandoned
- 1995-03-13 JP JP7052498A patent/JPH0840905A/ja active Pending
- 1995-03-13 FI FI951155A patent/FI951155A7/fi unknown
- 1995-03-13 AU AU14755/95A patent/AU694475B2/en not_active Ceased
- 1995-03-13 NO NO950950A patent/NO950950L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI951155A7 (fi) | 1995-09-15 |
| EP0672416A1 (en) | 1995-09-20 |
| CA2144500A1 (en) | 1995-09-15 |
| NO950950D0 (no) | 1995-03-13 |
| JPH0840905A (ja) | 1996-02-13 |
| AU694475B2 (en) | 1998-07-23 |
| NO950950L (no) | 1995-09-15 |
| AU1475595A (en) | 1995-09-21 |
| FI951155A0 (fi) | 1995-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0783302T3 (da) | Lægemidler | |
| FI970995L (fi) | Farmaseuttisia yhdisteitä | |
| FI971018L (fi) | Farmaseuttisia yhdisteitä | |
| NO954486D0 (no) | Farmasöytiske formuleringsgrunnlag | |
| FI973243L (fi) | Uusi farmaseuttinen yhdistelmä | |
| FI954243A7 (fi) | Farmaseuttiset yhdisteet | |
| EP0907644A4 (en) | PHARMACEUTICAL PREPARATION | |
| BR9507768A (pt) | Composição farmacêutica | |
| ITMI941169A0 (it) | Formulazioni farmaceutiche | |
| ITMI942166A0 (it) | Composizioni farmaceutiche miorilassanti | |
| FI973280A0 (fi) | Farmaseuttinen koostumus | |
| FI951155A7 (fi) | Farmaseuttinen valmiste | |
| BR9605777A (pt) | Composição farmacêutica | |
| FI954050L (fi) | Lääkekoostumuksia | |
| FI962738A0 (fi) | Farmaseuttiset koostumukset | |
| FI950737L (fi) | Lääkkeitä | |
| DE69503368D1 (de) | Dermatologisches präparat | |
| BR9605131A (pt) | Composição farmacêutica | |
| SK1380U (sk) | Farmaceutický preparát | |
| SE9402924D0 (sv) | Novel pharmaceutical composition | |
| ATA77096A (de) | Pharmazeutische präparation | |
| SE9302429D0 (sv) | New pharmaceutical preparation ii | |
| FI3862U1 (fi) | Geelimuotoinen farmaseuttinen valmiste | |
| SE9402131D0 (sv) | Läkemedel | |
| NO944330D0 (no) | Legemiddel |